![William Murphy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de William Murphy
Entité | Type d'entité | Industrie | |
---|---|---|---|
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI.
6
| Holding Company | Biotechnology | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à William Murphy via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
TCW Asset Management Co. LLC
![]() TCW Asset Management Co. LLC Investment ManagersFinance TCW Asset Management Co. LLC (TCW) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded in 1992 and is wholly-owned by The TCW Group, Inc. In 2013, TCW management and private investment funds affiliated with The Carlyle Group (NASDAQ: CG) acquired TCW Group from Société Générale. TCW provides investment management and advice for a wide array of investment strategies for institutional and individual investors through investment advisory accounts, private open- and closed-end commingled investment funds and structured investment vehicles such as collateralized debt obligations. | Investment Managers | Corporate Officer/Principal | |
AHT Corp.
![]() AHT Corp. Services to the Health IndustryHealth Services AHT Corp. is a national provider of Internet-based clinical e-commerce among physicians, other healthcare provides and healthcare organizations. The company is focused on automating laboratory and prescription transactions. Its products principally focus on laboratory and prescription connectivity and transaction processing, including within the laboratory suite of applications, Dr. Chart (R), Dr. Chart Web (TM), Compliance Monitor (TM), CDR (TM) and CDM (TM) and its electronic prescription writing product.. The company was founded by Edelson Jonathan on June 20, 1995 and is headquartered in Tarrytown, NY. | Services to the Health Industry | Director/Board Member | |
Invesco Advisers, Inc.
![]() Invesco Advisers, Inc. Investment ManagersFinance Invesco Advisers, Inc. is a SEC-registered investment advisor headquartered in Atlanta, Georgia. They are a subsidiary of Invesco Group Services, Inc., ultimately held by Invesco Ltd. (NYSE: IVZ). The firm was founded in 1986 and previously known as Invesco Institutional NA, Inc. until April 2010 when Invesco Ltd. consolidated the businesses of their US investment advisors (Invesco AIM Advisors, Inc., Invesco AIM Capital Management, Inc., Invesco AIM Private Asset Management, Inc. and Invesco Global Asset Management NA, Inc.) under the name Invesco Advisers, Inc. They provide discretionary and non-discretionary investment advisory services to individuals, institutional and high net-worth clients through separate accounts, wrap fee programs and US registered investment companies and other Commingled Funds. | Investment Managers | Corporate Officer/Principal | |
Ladenburg Thalmann & Co., Inc. (Broker)
![]() Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Investment Banks/Brokers | Chief Executive Officer | |
Anterios, Inc.
![]() Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Director/Board Member | |
California State University-Los Angeles | College/University | Undergraduate Degree | |
Loyola Marymount University | College/University | Masters Business Admin | |
University of Wisconsin | College/University | Undergraduate Degree | |
Ladenburg Thalmann & Co., Inc.
![]() Ladenburg Thalmann & Co., Inc. Regional BanksFinance Ladenburg Thalmann & Co., Inc. provides investment baking and brokerage services. The firm also provides asset and wealth management, underwriting, alternative investments and advisory services. It serves emerging growth companies and high net worth individuals. The company was founded in 1876 and is headquartered in New York, NY. | Regional Banks | Chief Executive Officer | |
mRNA RiboTherapeutics, Inc.
![]() mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Biotechnology | Director/Board Member | |
Case Western Reserve University School of Law | College/University | Graduate Degree | |
Case Western Reserve University School of Medicine | College/University | Graduate Degree | |
Eirion Therapeutics, Inc.
![]() Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eirion Therapeutics, Inc. is a clinical stage biopharmaceutical company that is developing prescription products for aesthetic dermatology. The company is based in Woburn, MA. The company has a pipeline of products that focus on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion plans to pursue additional indications that address other major unmet clinical needs for physicians and their patients. The company was founded in 2016. Jonathan T. Edelson has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member | |
Vascugen, Inc.
![]() Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Biotechnology | Founder Chief Executive Officer | |
Tacitus Therapeutics, Inc.
![]() Tacitus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tacitus Therapeutics, Inc. operates as a clinical-stage biotechnology firm. The company was founded by Ronald Hoffman and Camelia Iancu-Rubin and is headquartered in Albany, NY. | Miscellaneous Commercial Services | Chief Executive Officer | |
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
PEAK BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Blackriver Capital Management Ltd. | Founder |
Statistiques
Internationale
Etats-Unis | 25 |
Sectorielle
Finance | 11 |
Health Technology | 7 |
Consumer Services | 6 |
Health Services | 2 |
Commercial Services | 2 |
Opérationnelle
Director/Board Member | 11 |
Chief Executive Officer | 7 |
Corporate Officer/Principal | 6 |
Founder | 6 |
President | 4 |
Relations les plus connectées
Insiders | |
---|---|
Barry Kurokawa | 12 |
David Rosenberg | 7 |
Martin Ostrowski | 7 |
Carter Cliff | 3 |
Anna Clements | 1 |
Kurtis Knapp | 1 |
- Bourse
- Insiders
- William Murphy
- Connexions Sociétés